Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.

Cook JA, Hislop J, Altman DG, Fayers P, Briggs AH, Ramsay CR, Norrie JD, Harvey IM, Buckley B, Fergusson D, Ford I, Vale LD; DELTA group.

Trials. 2015 Jan 15;16(1):12. doi: 10.1186/s13063-014-0526-8.

2.

Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Hislop J, Adewuyi TE, Vale LD, Harrild K, Fraser C, Gurung T, Altman DG, Briggs AH, Fayers P, Ramsay CR, Norrie JD, Harvey IM, Buckley B, Cook JA; DELTA group.

PLoS Med. 2014 May 13;11(5):e1001645. doi: 10.1371/journal.pmed.1001645. eCollection 2014 May. Review.

3.

Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.

Cook JA, Hislop J, Adewuyi TE, Harrild K, Altman DG, Ramsay CR, Fraser C, Buckley B, Fayers P, Harvey I, Briggs AH, Norrie JD, Fergusson D, Ford I, Vale LD.

Health Technol Assess. 2014 May;18(28):v-vi, 1-175. doi: 10.3310/hta18280. Review.

4.

Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practice.

Cook JA, Hislop JM, Altman DG, Briggs AH, Fayers PM, Norrie JD, Ramsay CR, Harvey IM, Vale LD; for the DELTA group.

Clin Trials. 2014 Mar 6;11(3):300-308. [Epub ahead of print]

PMID:
24603006
5.

Guidance on minimally important clinical difference and trial size is needed.

Cook JA, Ramsay CR, Vale LD; DELTA Project Group.

BMJ. 2011 Jul 25;343:d4375. doi: 10.1136/bmj.d4375. No abstract available.

PMID:
21788268
6.

Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study.

Glaucoma screening Platform Study group, Burr JM, Campbell MK, Campbell SE, Francis JJ, Greene A, Hernández R, Hopkins D, McCann SK, Vale LD.

BMC Med Res Methodol. 2011 Apr 21;11:54. doi: 10.1186/1471-2288-11-54.

7.

Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients.

Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA; Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group.

BMJ. 2011 Mar 17;342:d1542. doi: 10.1136/bmj.d1542.

8.

A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study.

Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hernández R, Stewart K, Hammersley V, Hayavi S, McAteer A, Gray D, Daly F.

Health Technol Assess. 2009 Oct;13(47):iii-iv, ix-xi 1-130. doi: 10.3310/hta13470.

9.

Systematic review of economic evaluations of laparoscopic surgery for colorectal cancer.

Hernández RA, de Verteuil RM, Fraser CM, Vale LD; Aberdeen Health Technology Assessment Group.

Colorectal Dis. 2008 Nov;10(9):859-68. doi: 10.1111/j.1463-1318.2008.01609.x. Epub 2008 Jul 14. Review.

PMID:
18624821
10.

Economic evaluation of screening for open-angle glaucoma.

Hernández RA, Burr JM, Vale LD; OAG Screening Project Group.

Int J Technol Assess Health Care. 2008 Spring;24(2):203-11. doi: 10.1017/S0266462308080288.

PMID:
18400124
11.

Early treatment with prednisolone or acyclovir in Bell's palsy.

Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F.

N Engl J Med. 2007 Oct 18;357(16):1598-607.

12.

Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial).

Andrews PJ, Avenell A, Noble DW, Campbell MK, Battison CG, Croal BL, Simpson WG, Norrie J, Vale LD, Cook J, de Verteuil R, Milne AC; Trials Management Group.

Trials. 2007 Sep 20;8:25.

13.

Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial.

McNeill G, Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, Milne AC, Ramsay CR, Seymour DG, Stephen AI, Vale LD.

Nutr J. 2007 May 2;6:10.

14.

A cost-utility analysis of multivitamin and multimineral supplements in men and women aged 65 years and over.

Kilonzo MM, Vale LD, Cook JA, Milne AC, Stephen AI, Avenell A; MAVIS Trial Group.

Clin Nutr. 2007 Jun;26(3):364-70. Epub 2007 Jan 2.

PMID:
17198742
15.

The key role of micronutrients.

Avenell A, Campbell MK, Cook JA, Milne AC, Ramsay CR, Stephen AI, Hannaford, Kilonzo MM, Vale LD, McNeill G, Seymour DG.

Clin Nutr. 2007 Feb;26(1):159; author reply 160. Epub 2006 Aug 24. No abstract available.

PMID:
16934374
16.

Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial.

Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, McNeill G, Milne AC, Ramsay CR, Seymour DG, Stephen AI, Vale LD.

BMJ. 2005 Aug 6;331(7512):324-9.

17.

Low back pain: influence of early MR imaging or CT on treatment and outcome--multicenter randomized trial.

Gilbert FJ, Grant AM, Gillan MG, Vale LD, Campbell MK, Scott NW, Knight DJ, Wardlaw D; Scottish Back Trial Group.

Radiology. 2004 May;231(2):343-51. Epub 2004 Mar 18.

PMID:
15031430
18.

Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials.

Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, Donaldson C, Wallace SA, Lawrence PD, Khan IH.

Nephrol Dial Transplant. 2001 Feb;16(2):341-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk